Müssen Plättchenaggregationshemmer vor Operationen abgesetzt werden?

Literatur

• 1 Steinhubl S R, Berger P B, Mann J T 3rd, Fry E T, DeLago A, Wilmer C, Topol E J. CREDO Investigators . Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.  JAMA. 2002;  288 2411-2420
• 2 Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.  Lancet. 2000;  355 1295-1302
• 3 Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc J M, Morice M C, Maillard L, Pansieri M, Choussat R, Pinton P. ADMIRAL Investigators . Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.  N Engl J Med. 2001;  344 1895-1903
• 4 Reiter R A, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B. Desmopressin and platelets antagonize the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin.  Blood. 2003;  (elektronische Publikation)
• 5 Porte R J, Leebeek F W. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.  Drugs. 2002;  62 2193-2211
• 6 Kaluza G L, Joseph J, Lee J R, Raizner M E, Raizner A E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting.  J Am Coll Cardiol. 2000;  35 1288-1294
• 7 Yende S, Wunderink R G. Effect of clopidogrel on bleeding after coronary artery bypass surgery.  Crit Care Med. 2001;  29 2271-2275